Chuntuan Li

Chuntuan Li


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2018 in Journal of Hematology & Oncology
Verified
Journal Article
Open access
PDF file
WMWu Mei
Wu Mei
CLChuntuan Li
Chuntuan Li
ZPZhu Xiong Peng
Zhu Xiong Peng
FLT3 mutations are one of the most common findings in acute myeloid leukemia (AML). FLT3 inhibitors have been in active clinical development. Midostaurin as the first-in-class FLT3 inhibitor has been approved for treatment of patients with FLT3-mutated AML. In this review, we summarized the preclinical and clinical studies on new FLT3 inhibitors, including sorafenib, lestaurtinib, sunitinib, tandutinib, quizartinib, midostaurin, gilteritinib, crenolanib, cabozantinib, Sel24-B489, G-749, AMG 925, TTT-3002, and FF-10101. New generation FLT3 inhibitors and combination therapies may overcome resistance to first-generation agents.

1 October 2017
Verified
Journal Article
Closed access
LZLun-Huan Zhou
Lun-Huan Zhou
XZXiong-Peng Zhu
Xiong-Peng Zhu
HXHui-Fang Xiao
Hui-Fang Xiao
PXPeng-Liang Xin
Peng-Liang Xin
CLChuntuan Li
Chuntuan Li

29 October 2025 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
SLShengquan Liu
Shengquan Liu
SWShaoxiong Wang
Shaoxiong Wang
YXYahong Xu
Yahong Xu
YHYuanling Huang
Yuanling Huang
PXPengliang Xin
Pengliang Xin
CLChuntuan Li
Chuntuan Li
Natural killer/T-cell lymphoma (NKTCL) is a malignancy with a poor prognosis. The Smoothened (Smo) protein is implicated in NKTCL growth. This study employed lentiviral vector-mediated Smo RNA interference (LV- Smo -RNAi) to silence the Smo gene in the human NKTCL cell line SNT8. Fluorescence microscopy, qRT-PCR, and Western blot verified the reduction of Smo mRNA and protein levels. The CCK-8 assay showed that Smo silencing inhibited cell proliferation. Flow cytometry with annexin V-PE/7-AAD double staining indicated an increased apoptosis rate. Moreover, the expression of GLI family zinc finger 1 (Gli1) and programmed death-ligand 1 (PD-L1) was downregulated. In vivo, xenotransplantation experiments demonstrated that Smo silencing led to slower tumor growth with reduced tumor volume and weight. Overall, Smo gene silencing holds great potential as a novel molecular-targeted therapy approach for NKTCL by effectively suppressing cell proliferation and promoting apoptosis.